LITHIUM 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE HYDRATE
UNII RW7A85P7S5

Substance Identification & Data

This profile provides standardized clinical and technical data for Lithium 4,6-dichloropyridazine-3-carboxylate Hydrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RW7A85P7S5.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2245111-15-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RW7A85P7S5

CAS Registry Number

2245111-15-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LITHIUM 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE HYDRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C5HCl2N2O2.Li.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

KOGSKEZOKTYPFE-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154791965

Unique identification number in the NCBI database of chemical substances.

Substance Type

Lithium 4,6-dichloropyridazine-3-carboxylate hydrate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[O-]C(=O)c1nnc(Cl)cc1Cl.[Li+].O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lithium 4,6-dichloropyridazine-3-carboxylate Hydrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.